Day Two: Thursday April 25, 2019
REGISTRATION & COFFEE
8:00
Biomarkers & Companion Diagnostics
8:30
Exploratory Biomarkers in Breast Cancer R&D
Petar Jelinic
Director, Oncology Translational Science and Clinical Biomarkers
Merck
9:00
Liquid Biopsies Enabling Precision Medicine
Jonathan Beer
Director, Lead of Disruptive Technologies
Novartis
9:30
Examining the factors impacting concordance of plasma testing by next generation sequencing
Dan Stetson
Associate Principal Scientist
AstraZeneca
10:00
The use of comprehensive liquid biopsy in clinical trials and clinical practice
Elena Helman
Associate Director, Bioinformatics
Guardant Health
MORNING REFRESHMENTS & SPEED NETWORKING
10:30
11:00
Targeting somatic HER2 mutations in metastatic breast cancer: results from the phase II SUMMIT ‘basket’ trial
Al Lalani
Senior Vice President, Translational Medicine & Diagnostics
Puma Biotechnology
11:30
NKTR-214 plus NKTR-262, a Clinical Combination to Harness the Innate and the Adaptive Immune System
Ute Hoch
Executive Director
Nektar
LUNCH & NETWORKING
12:00
PANEL DISCUSSION
12:45
Participating:
Participants to be announced..
Novel Approaches in Breast Cancer Drug R&D
1:30
B-cell profiling from patients to discern novel public targets for breast cancer therapeutics
Amy Manning-Bog
Senior Director, Translational Sciences
Atreca
2:00
A Twenty-First Century Approach: From Primary Prevention to Intraductal Immunotherapy
Steven Quay
CEO
Atossa Genetics
AFTERNOON REFRESHMENTS & NETWORKING
2:30
2:45
Delivering an Rx/Dx solution for TNBC by targeting RSK2
Sandi Dunn
CEO
Phoenix Molecular
3:15
Crossing the Blood Brain Barrier: xB3 Peptide Enables Brain Penetration of Trastuzumab for the Treatment of HER2+ Breast Cancer Brain Metastases
Caroline Clairmont
Senior Vice President, R&D Operations
Bioasis
3:45
Theranostic applications in breast cancer
Christopher Adams
CEO
Andarix
4:15
Plinabulin, a Novel agent for CIN: Application in Breast Cancer.
Ramon Mohanlal
EVP R&D and CMO
BeyondSpring
SUMMARY & CLOSE OF CONFERENCE
4:45
VIEW PREVIOUS DAY
NEO SYNTH International House, 24 Holborn Viaduct, London EC1A 2BN
contact@neo-synth.com
(+1) 617.500.5172
Your details will not be shared with a third party
Copyright © 2016 | All content produced by: neo-synth ltd.